NHS Data Reveals Low Bowel Screening Uptake Among People in Their 50s

Newly released figures from NHS England indicate that people in their 50s are less likely to participate in bowel cancer screening compared to other eligible age groups. The data, covering the period from April 2024 to March 2025, shows a participation rate of 56.2% among 54-year-olds.

The national health service is highlighting these figures as part of an effort to understand and address the lower return rates for home testing kits in this demographic. Bowel cancer screening is offered to everyone aged 54 to 74 in England, with a faecal immunochemical test (FIT) kit sent through the post every two years.

Participation Gap in the 50s Age Bracket

According to the NHS England data, the uptake among those at the younger end of the screening programme is considerably lower than the national average for all eligible ages. The specific finding that just over half of 54-year-olds completed and returned their kit suggests a significant number of potential early cancer detections are being missed.

The FIT kit is designed to detect small amounts of blood in a stool sample, which can be an early sign of bowel cancer. The programme aims to identify the disease at a stage when treatment is more likely to be successful. Lower participation in this initial invitation group could therefore have implications for long-term health outcomes.

National Screening Programme Context

The bowel cancer screening programme was gradually expanded in recent years, with the age of first invitation lowered from 60 to 54. This expansion means a larger cohort of people in their 50s are now receiving kits for the first time. The data suggests that establishing a routine of completing and returning the test remains a challenge for this group.

While the NHS has not provided a single reason for the lower uptake, barriers to screening can include discomfort with the test process, a lack of symptoms leading to a perception of low personal risk, or simply forgetting to post the completed kit. The health service continues to monitor participation data closely to inform its public health messaging.